YBX1 and neoplasm: In our study, hsa-miR-1287-5p downregulated YBX1 by directly binding to its 3’ UTR, while circRAD23B indirectly upregulated YBX1 through the adsorption of hsa-miR-1287-5p, resulting in accelerated tumour proliferation and increased carboplatin resistance.